FLGT Q1 2025 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q1 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$73M+13.9% YoY

Gross Profit

$28M38.6% margin

Operating Income

-$20M-26.9% margin

Net Income

-$12M-15.7% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

-3.6%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$9M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$83M

Stockholders' Equity

$1.1B

Cash & Equivalents

$67M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73M	$64M	+13.9%
Gross Profit	$28M	$22M	+28.2%
Operating Income	-$20M	-$22M	+9.2%
Net Income	-$12M	-$13M	+14.4%

Revenue Segments

Laboratory Services

$73M100%

Geographic Segments

UNITED STATES

$68M86%

Non-US

$6M7%

Other Countries

$3M4%

CHINA

$3M3%